ORMDL3 and metabolic dysfunction-associated steatohepatitis: Our study uncovered a novel role of ORMDL3 in sexual dimorphism that is important for the development and progression of NASH, and highlights the sexually dimorphic nature of NASH and its link with fibrosis in humans.